New antibody drug treatments for lymphoma

By Mayes Sam   Brown Nick   Illidge Tim M  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 5, 2011-05 ,pp. : 623-640

Informa Healthcare

Access to resources Recommend Favorite

Antibody therapeutics:

By Jefferis Roy  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 9, 2007-09 ,pp. : 1401-1413

Informa Healthcare

Access to resources Recommend Favorite

Recognition of Human Activated CD44 by Tumor Vasculature-Targeted Antibody

By Taniguchi K.   Harada N.   Ohizumi I.   Tsutsumi Y.   Nakagawa S.   Kaiho S-i.   Mayumi T.  

Biochemical and Biophysical Research Communications, Vol. 269, Iss. 3, 2000-03 ,pp. : 671-675

Elsevier

Access to resources Recommend Favorite

Computational modelling and molecular dynamics simulations of a cyclic peptide mimotope of the CD52 antigen complexed with CAMPATH-1H antibody

By Stavrakoudis Athanassios  

Molecular Simulation, Vol. 36, Iss. 2, 2010-02 ,pp. : 127-137

Taylor & Francis Ltd

Access to resources Recommend Favorite

Toward a new generation of therapeutics: Artificial cell targeted delivery of live cells for therapy

By Prakash Satya   Martoni Christopher  

Applied Biochemistry and Biotechnology, Vol. 128, Iss. 1, 2006-01 ,pp. : 1-21

Humana Press, Inc

Access to resources Recommend Favorite